Company
United StatesMolecular Imaging Program at Stanford, Stanford, CA – FDA Inspections
Inspection records and compliance data for Molecular Imaging Program at Stanford in Stanford, California. 3 FDA inspections on record, 1 Form 483, last inspected October 04, 2024.
Company Profile
This profile covers Molecular Imaging Program at Stanford based in Stanford, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected October 6, 2010. Last inspected October 4, 2024.
Most cited issue areas
- Electronic records1 inspection
- Supplies adequately controlled1 inspection
- Written QA procedures established, followed1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 4, 2024 | VAI | Human Drugs · Drug Quality Assurance | 1251796 |
| November 3, 2015 | NAI | Human Drugs · Drug Quality Assurance | 947348 |
| October 6, 2010 | VAI | Human Drugs · Drug Quality Assurance | 683673 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Division of Nuclear Medicine PET Radiopharmaceutical Production Program
PETNET Solutions, Inc.
Pharmalogic Cincinnati, LLC
University Of Texas MD Anderson Cancer Center: PET
Kettering Medical Center
P.E.T.NET HOUSTON, LLC
Sofie Co.
Sofie Co dba Sofie
Wisconsin Medical Radiopharmacy, LLC.
The Methodist Hospital Research Institute
Company Information
Name
Molecular Imaging Program at Stanford
FEI Number
3005712028
Address
1201 Welch Rd, Stanford, California 94305, United States
Country
United States
ID: 2ebff17a-cb06-422f-a1d8-d32bae7f07ed